290 related articles for article (PubMed ID: 26194496)
41. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma.
Liu X; Ou H; Xiang L; Li X; Huang Y; Yang D
Oncotarget; 2017 Feb; 8(6):10510-10522. PubMed ID: 28060737
[TBL] [Abstract][Full Text] [Related]
42. MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1.
Liu Y; Ding Y; Huang J; Wang S; Ni W; Guan J; Li Q; Zhang Y; Ding Y; Chen B; Chen L
PLoS One; 2014; 9(2):e88393. PubMed ID: 24551096
[TBL] [Abstract][Full Text] [Related]
43. Circular RNA 101368/miR-200a axis modulates the migration of hepatocellular carcinoma through HMGB1/RAGE signaling.
Li S; Gu H; Huang Y; Peng Q; Zhou R; Yi P; Chen R; Huang Z; Hu X; Huang Y; Tang D
Cell Cycle; 2018; 17(19-20):2349-2359. PubMed ID: 30265210
[TBL] [Abstract][Full Text] [Related]
44. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
46. MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2.
Li H; Sun Q; Han B; Yu X; Hu B; Hu S
Int J Clin Exp Pathol; 2015; 8(5):4782-90. PubMed ID: 26191168
[TBL] [Abstract][Full Text] [Related]
47. miR-940 Suppresses Tumor Cell Invasion and Migration via Regulation of CXCR2 in Hepatocellular Carcinoma.
Ding D; Zhang Y; Yang R; Wang X; Ji G; Huo L; Shao Z; Li X
Biomed Res Int; 2016; 2016():7618342. PubMed ID: 27807540
[No Abstract] [Full Text] [Related]
48. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
Chen L; Luo L; Chen W; Xu HX; Chen F; Chen LZ; Zeng WT; Chen JS; Huang XH
Biomed Pharmacother; 2016 Dec; 84():1113-1118. PubMed ID: 27780140
[TBL] [Abstract][Full Text] [Related]
49. Oncogenic role of microRNA-423-5p in hepatocellular carcinoma.
Wu LM; Ji JS; Yang Z; Xing CY; Pan TT; Xie HY; Zhang F; Zhuang L; Zhou L; Zheng SS
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):613-8. PubMed ID: 26663009
[TBL] [Abstract][Full Text] [Related]
50. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
Jin Y; Wang J; Han J; Luo D; Sun Z
Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
[TBL] [Abstract][Full Text] [Related]
51. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
52. High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity.
Chen M; Liu Y; Varley P; Chang Y; He XX; Huang H; Tang D; Lotze MT; Lin J; Tsung A
Cancer Res; 2015 Apr; 75(8):1645-56. PubMed ID: 25720799
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
[TBL] [Abstract][Full Text] [Related]
54. MiR-940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients.
Yuan B; Liang Y; Wang D; Luo F
Cancer Sci; 2015 Jul; 106(7):819-24. PubMed ID: 25940592
[TBL] [Abstract][Full Text] [Related]
55. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
56. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
57. LINC00473 promotes hepatocellular carcinoma progression via acting as a ceRNA for microRNA-195 and increasing HMGA2 expression.
Mo J; Li B; Zhou Y; Xu Y; Jiang H; Cheng X; Wu X; Zhang Y
Biomed Pharmacother; 2019 Dec; 120():109403. PubMed ID: 31562977
[TBL] [Abstract][Full Text] [Related]
58. Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis.
Wang Z; Ding Q; Li Y; Liu Q; Wu W; Wu L; Yu H
Tumour Biol; 2016 Nov; 37(11):14779-14787. PubMed ID: 27633066
[TBL] [Abstract][Full Text] [Related]
59. Involvement of microRNA-718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cells.
Wang ZD; Qu FY; Chen YY; Ran ZS; Liu HY; Zhang HD
J Zhejiang Univ Sci B; 2017 Jan.; 18(1):27-36. PubMed ID: 28070994
[TBL] [Abstract][Full Text] [Related]
60. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]